Access Financial Services, Inc. Abbott Laboratories Transaction History

Access Financial Services, Inc.

$184 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $1,937 - $2,280	-20 Reduced 0.15%	13,742 $1.39 Million
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $36,883 - $43,269	-388 Reduced 2.74%	13,762 $0
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $22,351 - $25,878	231 Added 1.66%	14,150 $1.37 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $13,269 - $16,038	130 Added 0.94%	13,919 $1.51 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $117,440 - $143,211	1,030 Added 8.07%	13,789 $1.63 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $16,636 - $20,370	-144 Reduced 1.12%	12,759 $1.8 Million
Q3 2021 Oct 28, 2021	SELL	$116.66 - $129.06 $88,078 - $97,440	-755 Reduced 5.53%	12,903 $1.52 Million
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $915,718 - $1.08 Million	8,656 Added 173.05%	13,658 $1.58 Million
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $62,038 - $73,091	570 Added 12.86%	5,002 $599,000
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $45,675 - $49,772	-435 Reduced 8.94%	4,432 $485,000
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $21,535 - $26,153	-235 Reduced 4.61%	4,867 $530,000
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $9,954 - $12,740	-130 Reduced 2.48%	5,102 $466,000
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $30,342 - $44,368	-483 Reduced 8.45%	5,232 $413,000
Q4 2019 Jan 21, 2020	BUY	$78.51 - $87.4 $23,788 - $26,482	303 Added 5.6%	5,715 $496,000
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $14,576 - $17,000	-200 Reduced 3.56%	5,412 $455,000
Q1 2019 Apr 26, 2019	BUY	$66.22 - $80.06 $16,223 - $19,614	245 Added 4.56%	5,612 $449,000
Q4 2018 Feb 19, 2019	SELL	$65.56 - $74.27 $33,960 - $38,471	-518 Reduced 8.8%	5,367 $388,000
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $4,864 - $5,868	-80 Reduced 1.34%	5,885 $432,000
Q1 2018 Apr 27, 2018	SELL	$56.27 - $63.62 $9,453 - $10,688	-168 Reduced 2.74%	5,965 $357,000
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $2,684 - $2,873	-50 Reduced 0.81%	6,133 $350,000
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $297,154 - $331,656	6,183	6,183 $330,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.05 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.76 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.29 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Access Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Access Financial Services, Inc. with notifications on news.

Account